The bill would make federal agencies review lung cancer research and screening for women and underserved groups. It would require a report to Congress within two years, but it would not directly start new programs.
Modern Action explains legislation in plain English, helps you choose whether to support, oppose, or ask for changes, and drafts a message tied to the bill, your stance, and the elected officials who can act on it.
Women and Lung Cancer Research and Preventive Services Act of 2025 is a Senate bill waiting for floor action. The latest recorded action: Received in the Senate. Read twice. Placed on Senate Legislative Calendar under General Orders. Calendar No. 380.
Latest action on H.R. 2319: Received in the Senate. Read twice. Placed on Senate Legislative Calendar under General Orders. Calendar No. 380.
Who this affects: This bill mainly affects women and underserved people who already meet federal lung cancer screening guidelines. It could also affect doctors, hospitals, researchers, veterans' health systems, and federal agencies that work on cancer research or screening. Any real change for patients would depend on what Congress or agencies do after the report.
Why this matters: Lung cancer kills many people, and the bill focuses on groups that may face missed risks or barriers to screening. A federal review could show where research, public education, and screening access fall short. The report could guide future laws or funding, but the bill itself does not create those later changes.
You do not have to start with a blank letter. Modern Action turns the bill, your position, and the relevant congressional context into a message you can edit and send. The goal is to make contacting Congress clear, specific, and useful without forcing you to parse bill text or figure out the right office on your own.
Keep acting on Modern Action
Compare the broader issue and related bills without leaving Modern Action.
